Papillary muscle scarring (papSCAR) is prevalent in one-third of DCM patients and predicts cardiac death independently. The FIDDLE technique significantly improves papSCAR detection sensitivity ...
Background A 67-year-old man was admitted to a coronary care unit for non-ST-segment elevation myocardial infarction with complicating acute heart failure. Severe mitral regurgitation was detected by ...
NCCN now includes Anktiva plus BCG for BCG-unresponsive papillary-only NMIBC, acknowledging an unmet need in patients without ...
TCT 1019: Complex degenerative mitral valve disease with a posterior cleft and severe regurgitation successfully treated using a single PASCAL Ace device with horizontal positioning. Receive the the ...
The combination of nogapendekin alfa inbakicept-pmln (Anktiva) and Bacillus Calmette-Guérin was added to the NCCN clinical ...
NCCN has added ImmunityBio's ANKTIVA to its Clinical Practice Guidelines for BCG-unresponsive non muscle invasive bladder cancer with papillary only disease. This update extends recognized use of ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Study honoraria to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results